The price of Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares last traded on Wall Street unchanged to $1.28.
DNA stock price is now -25.22% away from the 50-day moving average and -23.27% away from the 200-day moving average. The market capitalization of the company currently stands at $2.50B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, Kelly Jason R, insider sold 100,000 shares of the company’s stock on Nov 09. The stock was sold for $129,100 at an average price of $1.29. Upon completion of the transaction, the insider now directly owns 5,294,680 shares in the company, valued at $6.78 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 09, Shetty Reshma P. sold 37,650 shares of the business’s stock. A total of $48,531 was realized by selling the stock at an average price of $1.29. This leaves the insider owning 12,600,444 shares of the company worth $16.13 million. Insiders disposed of 36,609,057 shares of company stock worth roughly $46.86 million over the past 1 year. A total of 35.10% of the company’s stock is owned by insiders.
A candlestick chart of Ginkgo Bioworks Holdings Inc (NYSE: DNA) showed a price of $1.3500 on Monday morning. During the past 12 months, Ginkgo Bioworks Holdings Inc has had a low of $1.12 and a high of $2.94. As of last week, the company has a debt-to-equity ratio of 0.32, a current ratio of 6.78, and a quick ratio of 6.78. The fifty day moving average price for DNA is $1.7118 and a two-hundred day moving average price translates $1.6681 for the stock.
The latest earnings results from Ginkgo Bioworks Holdings Inc (NYSE: DNA) was released for Sep, 2023. According to the Biotechnology Company, earnings per share came in at -$0.16, missing analysts’ expectations of -$0.09 by -0.07. This compares to -$0.41 EPS in the same period last year. The net profit margin was -272.30% and return on equity was -63.83% for DNA. The company reported revenue of $55.43 million for the quarter, compared to $66.4 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -16.52 percent. For the current quarter, analysts expect DNA to generate $42.37M in revenue.
